IDEAYA Biosciences, Inc.
IDYA
$17.45
-$0.90-4.91%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -307.08M | -274.48M | -178.12M | -153.74M | -128.89M |
| Total Depreciation and Amortization | 3.89M | 3.83M | 4.22M | 4.23M | 4.13M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 17.97M | 11.51M | 7.87M | 5.75M | 4.83M |
| Change in Net Operating Assets | 21.11M | 11.55M | 16.36M | 13.14M | -11.26M |
| Cash from Operations | -264.11M | -247.58M | -149.68M | -130.62M | -131.20M |
| Capital Expenditure | -3.86M | -3.86M | -3.59M | -3.74M | -3.65M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -64.91M | -498.70M | -413.80M | -342.27M | -532.30M |
| Cash from Investing | -68.77M | -502.56M | -417.39M | -346.01M | -535.95M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 345.18M | 668.15M | 799.24M | 549.97M | 666.72M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 9.40M | 9.40M | 16.45M | 7.05M | 42.18M |
| Cash from Financing | 354.58M | 677.55M | 815.69M | 557.02M | 708.90M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 21.70M | -72.59M | 248.62M | 80.40M | 41.76M |